BeStock  
Markets › Compare › NKTR vs AAPG

NKTR vs AAPG

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
NKTR · Nektar Therapeutics$30.20 ▼ 7.19%
AAPG · Ascentage Pharma$11.97 ▼ 3.78%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

2967104142179Nov 24, '25May 26, '26Nov 20, '26
  • NKTR -48.5%
  • AAPG -62.6%

Head to head

MetricNKTRAAPG
Price$30.20$11.97
Change today▼ 7.19%▼ 3.78%
Market cap$1.03B$1.12B
Return, 3 months-59.0%-28.4%
Return, year to date-28.6%-54.4%
Return, 1 year-44.4%-60.9%
P/E (TTM)––
P/B1.213.4
P/E percentile vs own 5y20th98th
Dividend yield––
Revenue growth (YoY, latest qtr)-20.4%-41.5%
Net profit growth (YoY)-56.7%-206.4%
Gross margin–93.9%
Operating margin-303.6%-216.7%
Net margin-339.7%-228.5%
Return on equity-37.9%-240.3%
Analyst target vs. price+356.1%+250.9%
Analyst buy share70%100%
RSI (14)2329
30-day volatility53.9%64.7%
Max drawdown, 1 year-69.9%-65.1%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • AAPG is the largest of the group by market value.
  • NKTR has returned the most over the past year.
  • NKTR is growing revenue fastest.
  • AAPG keeps the most profit per dollar of sales.
  • NKTR has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top